Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

LUNG

Pulmonx Corp

Feb 11 • 04:00PM ET

1.45

0.00 0.00 %

Healthcare • Medical Devices • USA • NASD

Peers: DHR MDT EW ISRG SYK BSX ZBH HOLX XRAY ALGN

| Held by: VTI IWM VXF IWO VTWO IWC ITOT VTWG RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-1.41	Insider Own	13.10%	Shs Outstand	41.25M	Perf Week	-3.33%
Market Cap	59.81M	Forward P/E	-	EPS next Y	-1.34	Insider Trans	-1.51%	Shs Float	35.84M	Perf Month	-27.14%
Enterprise Value	39.56M	PEG	-	EPS next Q	-0.39	Inst Own	77.65%	Short Float	7.86%	Perf Quarter	-25.26%
Income	-56.75M	P/S	0.65	EPS this Y	-1.62%	Inst Trans	-8.41%	Short Ratio	3.84	Perf Half Y	-8.81%
Sales	91.66M	P/B	1.00	EPS next Y	8.66%	ROA	-37.13%	Short Interest	2.82M	Perf YTD	-34.39%
Book/sh	1.46	P/C	0.78	EPS next 5Y	14.12%	ROE	-73.73%	52W High	9.37 -84.53%	Perf Year	-78.77%
Cash/sh	1.86	P/FCF	-	EPS past 3/5Y	-2.30% -19.80%	ROIC	-49.20%	52W Low	1.31 10.69%	Perf 3Y	-83.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.06% 20.78%	Gross Margin	73.08%	Volatility	6.89% 6.32%	Perf 5Y	-97.56%
Dividend TTM	-	EV/Sales	0.43	EPS Y/Y TTM	4.13%	Oper. Margin	-62.38%	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.15	Sales Y/Y TTM	15.59%	Profit Margin	-61.91%	RSI (14)	30.39	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	4.86	EPS Q/Q	5.33%	SMA20	-14.00%	Beta	0.08	Target Price	5.75
Payout	-	Debt/Eq	0.94	Sales Q/Q	5.47%	SMA50	-28.08%	Rel Volume	0.52	Prev Close	1.45
Employees	291	LT Debt/Eq	0.92	Earnings	Nov 12 AMC	SMA200	-35.54%	Avg Volume	733.60K	Price	1.45
IPO	Oct 01, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.43% 2.49%	Trades		Volume	382,298	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-25	Downgrade	Piper Sandler	Overweight → Neutral	$2.50
Mar-10-25	Initiated	D. Boral Capital	Buy	$17
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$17 → $7.50
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49

Show Previous Ratings

Dec-03-25 04:05PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.00% +13.23%
Nov-13-25 12:01AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... (GuruFocus.com) -18.88%
Nov-12-25 05:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.22%
04:05PM	Pulmonx Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:15PM	American Well Corporation (AMWL) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -6.01%
05:43AM	Loading…
Oct-31-25 05:43AM	Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? (Insider Monkey) +13.64%
Oct-28-25 10:03AM	Pulmonx Corp (LUNG) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +26.92%
Oct-27-25 04:05PM	Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 (GlobeNewswire)
Oct-15-25 04:05PM	Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 (GlobeNewswire)
Aug-27-25 12:00PM	What Makes Pulmonx (LUNG) a New Buy Stock (Zacks) +5.08%
Aug-26-25 04:05PM	Pulmonx to Participate in September Investor Conferences (GlobeNewswire) +5.99%
Aug-11-25 05:00AM	Apreo raises $130M for pivotal trial of emphysema device (MedTech Dive)
Aug-05-25 09:35AM	After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) (Zacks)
Jul-31-25 03:33AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges (GuruFocus.com) -41.59%
Jul-30-25 06:00PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	Pulmonx Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 04:05PM	Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
10:05AM	Pulmonx Corp (LUNG) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-16-25 04:05PM	Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 (GlobeNewswire) +7.78% +6.19%
May-28-25 04:05PM	Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +8.11%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
May-01-25 04:05PM	Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference (GlobeNewswire) -21.95%
10:06AM	Q1 2025 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:18AM	Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... (GuruFocus.com)
Apr-30-25 08:25PM	Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript (Seeking Alpha) -8.35%
06:10PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 04:05PM	Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025 (GlobeNewswire) -5.64%
06:53AM	P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? (Zacks)
Apr-10-25 11:38AM	Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? (Zacks)
01:14PM	Loading…
Feb-20-25 01:14PM	Q4 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +32.23%
02:12AM	Pulmonx Corp (LUNG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Financial ... (GuruFocus.com)
Feb-19-25 05:20PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.01%
04:05PM	Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
04:58AM	What To Expect From Pulmonx Corp (LUNG) Q4 2024 Earnings (GuruFocus.com)
Feb-13-25 04:05PM	Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day (GlobeNewswire) +5.28% -5.56%
Feb-05-25 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire) +6.59%
Nov-21-24 09:55AM	Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? (Zacks)
Nov-20-24 04:05PM	Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 09:00AM	Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers (Business Wire)
Nov-07-24 04:05PM	Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-24 04:05PM	Pulmonx to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire) +8.44%
09:55AM	Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know (Zacks)
Oct-31-24 07:00AM	Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com) -7.95%
Oct-30-24 06:25PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 04:05PM	Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire) -5.74%
Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-07-24 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Dec-22-23 11:19PM	Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Dec-11-23 09:00AM	The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors (GlobeNewswire)
Nov-17-23 01:08PM	Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare (InvestorPlace)
Nov-15-23 04:05PM	Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Oct-31-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire) +11.41%
09:00AM	Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:03AM	Q3 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-23 06:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:53PM	Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results (GuruFocus.com)
04:05PM	Pulmonx Reports Record Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:05PM	Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023 (GlobeNewswire)
Oct-10-23 04:05PM	Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue (GlobeNewswire) -13.36%
Aug-30-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-02-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) +7.23%
Jul-19-23 04:05PM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-17-23 08:00AM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-10-23 08:47AM	Shareholders in Pulmonx (NASDAQ:LUNG) are in the red if they invested a year ago (Simply Wall St.)
May-03-23 10:43AM	Q1 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +8.63%
May-02-23 05:35PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.90%
04:05PM	Pulmonx Reports First Quarter 2023 Financial Results (GlobeNewswire)

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STEVEN WILLIAMSON	Officer	Jan 22 '26	Proposed Sale	1.95	48,892	95,339		Jan 22 04:02 PM
STEVEN WILLIAMSON	Officer	Jan 15 '26	Proposed Sale	1.95	15,892	31,039		Jan 15 05:49 PM
STEVEN WILLIAMSON	Officer	Jan 14 '26	Proposed Sale	2.00	31,082	62,074		Jan 14 05:13 PM
Florin Daniel P	Director	Dec 08 '25	Sale	1.99	23,321	46,409	93,910	Dec 09 05:59 PM
DANIEL P FLORIN	Director	Dec 08 '25	Proposed Sale	1.99	23,321	46,385		Dec 08 06:26 PM
French Glendon E. III	President and CEO	Dec 01 '25	Sale	1.57	8,805	13,824	277,324	Dec 03 07:51 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Dec 01 '25	Sale	1.57	6,322	9,926	373,466	Dec 03 07:48 PM
Lehman David Aaron	GENERAL COUNSEL	Dec 01 '25	Sale	1.57	10,278	16,136	252,992	Dec 03 07:43 PM
Williamson Steven S.	PRESIDENT AND CEO	Sep 02 '25	Sale	1.60	9,648	15,437	358,967	Sep 03 05:14 PM
Joshi Mehul	Chief Financial Officer & PAO	Sep 02 '25	Sale	1.60	7,936	12,698	208,489	Sep 03 05:12 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Sep 02 '25	Sale	1.60	6,543	10,469	379,788	Sep 03 05:10 PM
Lehman David Aaron	GENERAL COUNSEL	Sep 02 '25	Sale	1.60	9,769	15,630	263,270	Sep 03 05:08 PM
Ferrari Richard	Director	Jun 12 '25	Sale	3.16	8,000	25,280	87,024	Jun 13 05:38 PM
Ferrari Richard	Director	Jun 13 '25	Proposed Sale	3.01	5,438	16,368		Jun 13 11:47 AM
RICH FERRARI	Director	Jun 12 '25	Proposed Sale	3.16	8,000	25,307		Jun 12 05:24 PM
Florin Daniel P	Director	Jun 05 '25	Buy	3.06	23,321	71,362	117,231	Jun 05 08:39 PM
Williamson Steven S.	PRESIDENT AND CEO	Jun 02 '25	Sale	3.13	9,923	31,059	366,115	Jun 04 06:13 PM
Joshi Mehul	Chief Financial Officer & PAO	Jun 02 '25	Sale	3.13	8,061	25,231	213,925	Jun 04 06:10 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 02 '25	Sale	3.13	6,947	21,748	386,331	Jun 04 06:04 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 02 '25	Sale	3.13	10,457	32,736	273,039	Jun 04 06:02 PM
French Glendon E. III	Director	Mar 20 '25	Sale	7.85	20,000	157,000	991,974	Mar 21 06:14 PM
GLENDON FRENCH	Director	Mar 20 '25	Proposed Sale	7.77	60,000	466,200		Mar 20 04:19 PM
Joshi Mehul	Chief Financial Officer & PAO	Mar 03 '25	Sale	7.12	14,384	102,414	113,986	Mar 05 06:12 PM
Williamson Steven S.	PRESIDENT AND CEO	Mar 03 '25	Sale	7.14	27,689	197,699	194,342	Mar 05 06:09 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 03 '25	Sale	7.65	22,355	170,921	175,496	Mar 05 06:04 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 03 '25	Sale	7.13	5,779	41,193	285,278	Mar 05 06:02 PM
DAVID LEHMAN	Officer	Mar 03 '25	Proposed Sale	7.97	13,622	108,569		Mar 03 04:44 PM
French Glendon E. III	Director	Feb 20 '25	Sale	8.28	55,453	459,086	1,011,974	Feb 24 05:50 PM
GLENDON FRENCH	Officer	Feb 20 '25	Proposed Sale	6.64	55,453	368,208		Feb 20 04:22 PM

Open in Screener

OM

Outset Medical Inc

Feb 11 • 04:00PM ET

4.54

-0.16 -3.40 %

Healthcare • Medical Devices • USA • NASD

Peers: FMS BAX PODD INSP RMD AXNX NARI NVRO OFIX MDXG

| Held by: VTI IWM VXF IWN VTWO IWO DFAS IWC ITOT FMED

Index	RUT	P/E	-	EPS (ttm)	-13.00	Insider Own	4.07%	Shs Outstand	17.81M	Perf Week	-7.35%
Market Cap	82.32M	Forward P/E	-	EPS next Y	-2.66	Insider Trans	-4.84%	Shs Float	17.41M	Perf Month	-18.49%
Enterprise Value	6.20M	PEG	-	EPS next Q	-0.67	Inst Own	105.58%	Short Float	13.02%	Perf Quarter	-62.39%
Income	-87.80M	P/S	0.69	EPS this Y	83.42%	Inst Trans	-4.89%	Short Ratio	2.24	Perf Half Y	-64.17%
Sales	120.07M	P/B	0.58	EPS next Y	40.31%	ROA	-30.80%	Short Interest	2.27M	Perf YTD	22.37%
Book/sh	7.78	P/C	0.46	EPS next 5Y	55.30%	ROE	-92.33%	52W High	21.98 -79.34%	Perf Year	-61.92%
Cash/sh	9.85	P/FCF	-	EPS past 3/5Y	5.23% -4.06%	ROIC	-36.72%	52W Low	3.10 46.45%	Perf 3Y	-98.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	3.48% 49.79%	Gross Margin	37.74%	Volatility	6.76% 9.46%	Perf 5Y	-99.47%
Dividend TTM	-	EV/Sales	0.05	EPS Y/Y TTM	68.71%	Oper. Margin	-57.92%	ATR (14)	0.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.77	Sales Y/Y TTM	4.65%	Profit Margin	-73.12%	RSI (14)	44.72	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	7.09	EPS Q/Q	87.91%	SMA20	-9.42%	Beta	2.08	Target Price	11.75
Payout	-	Debt/Eq	0.69	Sales Q/Q	2.67%	SMA50	1.77%	Rel Volume	0.47	Prev Close	4.70
Employees	-	LT Debt/Eq	0.68	Earnings	Feb 11 AMC	SMA200	-63.07%	Avg Volume	1.01M	Price	4.54
IPO	Sep 15, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.34% -4.23%	Trades		Volume	472,854	Change	-3.40%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6 → $3
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$5 → $6
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

Today 04:02PM	Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-10-26 07:26AM	Outset Medical Inc (OM) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-09-26 02:14PM	Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating (Insider Monkey)
Jan-28-26 12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks) -11.53%
06:49AM	Outset Medical secures FDA clearance for Tablo haemodialysis system (Medical Device Network)
09:00AM	Loading…
Jan-27-26 09:00AM	Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned (GlobeNewswire) +14.29%
Jan-26-26 04:05PM	Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 (GlobeNewswire)
Jan-13-26 04:41AM	Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? (Zacks) -8.08%
Jan-12-26 08:30AM	Outset Medical Reports Unaudited Fourth Quarter and 2025 Results (GlobeNewswire) +22.15%
Jan-05-26 04:05PM	Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +12.89%
Nov-11-25 12:02AM	Outset Medical Inc (OM) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -48.47%
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Third-Quarter Results (GlobeNewswire)
Nov-07-25 07:23AM	Earnings To Watch: Outset Medical Inc (OM) Reports Q3 2025 Result (GuruFocus.com)
Nov-06-25 05:55PM	10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) -5.97%
04:05PM	Loading…
Nov-05-25 04:05PM	New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo Hemodialysis System (GlobeNewswire)
09:00AM	Outset Medical to Present at the 2025 Stifel Healthcare Conference (GlobeNewswire)
Oct-27-25 04:05PM	Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 (GlobeNewswire)
Sep-12-25 08:43AM	Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar? (Zacks)
Sep-03-25 09:00AM	Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis (GlobeNewswire)
Aug-20-25 04:05PM	Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-15-25 09:35AM	After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM) (Zacks)
Aug-06-25 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -6.60% +7.67%
04:02PM	Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization (GlobeNewswire)
Aug-05-25 10:24AM	What To Expect From Outset Medical Inc (OM) Q2 2025 Earnings (GuruFocus.com)
Aug-04-25 06:05PM	Inspire Medical Systems (INSP) Q2 Earnings and Revenues Surpass Estimates (Zacks) -5.85%
Jul-30-25 09:01AM	Outset Medical Names First Chief Nursing Officer (GlobeNewswire)
Jul-16-25 04:03PM	Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 (GlobeNewswire)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
Jun-25-25 07:59AM	Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength? (Zacks)
08:19AM	Loading…
Jun-24-25 08:19AM	FMS Stock Likely to Gain on New Optimization Plan FME Reignite (Zacks) +14.97%
Jun-05-25 09:05AM	Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-25 04:30PM	Outset Medical Appoints Renee Gaeta as Chief Financial Officer (GlobeNewswire) +8.98%
May-29-25 05:04PM	Osisko Metals Announces Voting Results of Annual and Special Meeting of Shareholders (GlobeNewswire) -9.69%
May-14-25 09:00AM	Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors (GlobeNewswire) +7.31%
May-09-25 09:00AM	Outset Medical to Present at RBC Global Healthcare Conference (GlobeNewswire)
May-08-25 09:50AM	Q1 2025 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents) +35.26%
03:37AM	Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-07-25 09:30PM	Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:25PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined (GlobeNewswire)
May-05-25 07:00AM	Osisko Metals Intersects 323 Metres Averaging 0.43% Cu at Gaspe Project (GlobeNewswire)
May-01-25 06:25PM	American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +9.67%
Apr-21-25 09:55AM	Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? (Zacks) -9.36%
Apr-16-25 04:32PM	Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 (GlobeNewswire)
10:38AM	Outset Medical: The Worst Is Over, But Execution Risk Remains High (Seeking Alpha)
05:00AM	90-Day Tariff Pause: Which Cryptocurrencies Should You Be Buying Now? (Motley Fool)
Apr-02-25 09:55AM	Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know (Zacks) +11.37%
Mar-21-25 06:35AM	Why Outset Medical Inc. (OM) Surged On Thursday? (InsiderMonkey) -10.90%
Mar-18-25 08:30AM	Outset Medical Announces One-for-Fifteen Reverse Stock Split (GlobeNewswire)
Feb-26-25 09:55AM	Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now (Zacks) -6.51%
Feb-24-25 04:03PM	Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire) -6.82%
Feb-20-25 02:14PM	Q4 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-25 05:15PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:03PM	Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
05:00AM	Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 04:35PM	Outset Medical Announces Resolution of Warning Letter (GlobeNewswire) +5.12% +9.65%
Feb-12-25 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-03-25 09:00AM	Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 (GlobeNewswire)
Jan-08-25 09:00AM	Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -11.22%
Jan-07-25 05:29AM	Outset Medical to pay down debt after raising nearly $300M (MedTech Dive) -13.39%
Jan-06-25 08:30AM	Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors (GlobeNewswire) -9.29%
Nov-15-24 09:00AM	Outset Medical to Present at the 2024 Stifel Healthcare Conference (GlobeNewswire) -8.01%
Nov-11-24 10:05AM	Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance (Insider Monkey) +11.24%
Nov-07-24 04:00PM	Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) +25.18%
Nov-06-24 05:25PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 08:09AM	Outset Medical Inc (OM) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-23-24 04:05PM	New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo (GlobeNewswire) -6.06%
09:00AM	Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024 (GlobeNewswire)
Oct-18-24 04:25AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (Newsfile)
Oct-16-24 06:56PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -7.94%
Oct-14-24 01:27PM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights OM (GlobeNewswire)
Oct-11-24 06:45AM	Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-27-24 08:26AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) +16.12%
Sep-23-24 03:57PM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire) -10.12%
Sep-20-24 09:13AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire)
Sep-17-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-13-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire) +17.67%
Sep-12-24 01:23AM	Analysis of AMERIPRISE FINANCIAL INC's Recent Trade in Outset Medical Inc (GuruFocus.com) -11.69%
01:14AM	Morgan Stanley's Strategic Reduction in Outset Medical Inc Shares (GuruFocus.com)
01:08AM	JPMorgan Chase & Co's Strategic Reduction in Outset Medical Inc (GuruFocus.com)
Sep-11-24 03:44PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-09-24 04:10PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-06-24 01:47PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-04-24 03:23PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-03-24 11:57AM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-31-24 05:52PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, BrightSpring, Outset, and NuScale and Encourages Investors to Contact the Firm (GlobeNewswire) -5.28%
Aug-07-24 06:35PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -68.53%
04:03PM	Outset Medical Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-31-24 10:01AM	Will Outset Medical, Inc. (OM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-24-24 09:00AM	Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 (Business Wire) -5.65%
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
Jun-10-24 12:00PM	Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -8.44%
Jun-03-24 04:05PM	Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 06:59AM	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:48PM	Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses (GuruFocus.com) -6.12%
May-09-24 03:44PM	Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript (Insider Monkey) -20.82%

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nash Marc	EVP Operations R&D & Service	Jan 20 '26	Sale	5.12	5,375	27,520	42,785	Jan 21 07:07 PM
Nash Marc	EVP Operations R&D & Service	Jan 21 '26	Sale	4.98	980	4,880	41,805	Jan 21 07:07 PM
Brottem John L.	General Counsel	Jan 20 '26	Sale	5.12	9,314	47,688	36,957	Jan 21 07:05 PM
Brottem John L.	General Counsel	Jan 21 '26	Sale	5.01	1,180	5,912	35,777	Jan 21 07:05 PM
Trigg Leslie	Chair and CEO	Jan 20 '26	Sale	5.12	11,794	60,385	107,823	Jan 21 06:54 PM
Trigg Leslie	Chair and CEO	Jan 21 '26	Sale	5.05	2,120	10,706	105,703	Jan 21 06:54 PM
Trigg Leslie	Officer	Jan 21 '26	Proposed Sale	5.05	2,120	10,697		Jan 21 06:29 PM
Nash Marc	Officer	Jan 21 '26	Proposed Sale	4.98	980	4,876		Jan 21 06:26 PM
Brottem John L.	Officer	Jan 21 '26	Proposed Sale	5.01	1,180	5,914		Jan 21 06:25 PM
Nash Marc	Officer	Jan 20 '26	Proposed Sale	5.12	5,375	27,520		Jan 20 08:13 PM
Trigg Leslie	Officer	Jan 20 '26	Proposed Sale	5.12	11,794	60,385		Jan 20 08:12 PM
Brottem John L.	Officer	Jan 20 '26	Proposed Sale	5.12	9,314	47,683		Jan 20 08:11 PM
Nash Marc	EVP Operations R&D & Service	Jan 07 '26	Sale	4.27	108	461	48,160	Jan 08 05:10 PM
Brottem John L.	General Counsel	Jan 07 '26	Sale	4.27	224	956	46,271	Jan 08 05:09 PM
Trigg Leslie	Chair and CEO	Jan 07 '26	Sale	4.27	1,795	7,665	119,617	Jan 08 05:05 PM
Nash Marc	Officer	Jan 07 '26	Proposed Sale	4.27	108	461		Jan 07 06:09 PM
Trigg Leslie	Officer	Jan 07 '26	Proposed Sale	4.27	1,795	7,665		Jan 07 06:07 PM
Brottem John L.	Officer	Jan 07 '26	Proposed Sale	4.27	224	956		Jan 07 06:05 PM
Drexler Karen	Director	Dec 01 '25	Sale	4.37	1,548	6,765	10,650	Dec 02 05:39 PM
Trigg Leslie	Chair and CEO	Nov 17 '25	Sale	4.60	916	4,214	121,412	Nov 18 04:37 PM
Nash Marc	EVP Operations R&D & Service	Nov 17 '25	Sale	4.60	247	1,136	48,268	Nov 18 04:33 PM
Brottem John L.	General Counsel	Nov 17 '25	Sale	4.60	388	1,785	46,495	Nov 18 04:28 PM
Nash Marc	Officer	Nov 17 '25	Proposed Sale	4.60	247	1,136		Nov 17 06:48 PM
Trigg Leslie	Officer	Nov 17 '25	Proposed Sale	4.60	916	4,214		Nov 17 06:45 PM
Brottem John L.	Officer	Nov 17 '25	Proposed Sale	4.60	388	1,785		Nov 17 06:43 PM
Trigg Leslie	Chair and CEO	Aug 15 '25	Sale	12.88	904	11,644	122,328	Aug 18 04:05 PM
Nash Marc	SVP Operations and R&D	Aug 15 '25	Sale	12.88	243	3,130	42,898	Aug 18 04:01 PM
Brottem John L.	General Counsel	Aug 15 '25	Sale	12.88	383	4,933	46,883	Aug 18 04:00 PM
Trigg Leslie	Officer	Aug 15 '25	Proposed Sale	12.88	904	11,644		Aug 15 07:57 PM
Brottem John L.	Officer	Aug 15 '25	Proposed Sale	12.88	383	4,933		Aug 15 07:53 PM
Nash Marc	Officer	Aug 15 '25	Proposed Sale	12.88	243	3,130		Aug 15 07:48 PM
Trigg Leslie	Chair and CEO	May 15 '25	Sale	17.80	935	16,643	58,129	May 16 05:24 PM
Nash Marc	SVP Operations and R&D	May 15 '25	Sale	17.82	252	4,491	13,465	May 16 05:22 PM
Brottem John L.	General Counsel	May 15 '25	Sale	17.82	396	7,057	11,273	May 16 05:21 PM
Ahmed Nabeel	Chief Financial Officer	May 15 '25	Sale	17.81	584	10,401	16,096	May 16 05:20 PM
Ahmed Nabeel	Officer	May 15 '25	Proposed Sale	17.82	584	10,405		May 15 06:07 PM
Trigg Leslie	Officer	May 15 '25	Proposed Sale	17.80	935	16,646		May 15 05:57 PM
Brottem John L.	Officer	May 15 '25	Proposed Sale	17.82	396	7,058		May 15 05:48 PM
Nash Marc	Officer	May 15 '25	Proposed Sale	17.82	252	4,490		May 15 05:48 PM
Trigg Leslie	Chair and CEO	Feb 18 '25	Sale	0.90	14,611	13,150	880,969	Feb 19 04:30 PM
Nash Marc	SVP Operations and R&D	Feb 18 '25	Sale	0.90	4,204	3,784	200,764	Feb 19 04:29 PM
Brottem John L.	General Counsel	Feb 18 '25	Sale	0.90	6,145	5,530	175,043	Feb 19 04:26 PM
Ahmed Nabeel	Chief Financial Officer	Feb 18 '25	Sale	0.90	8,659	7,793	250,210	Feb 19 04:23 PM
Trigg Leslie	Officer	Feb 18 '25	Proposed Sale	0.90	14,611	13,150		Feb 18 07:18 PM
Nash Marc	Officer	Feb 18 '25	Proposed Sale	0.90	4,204	3,784		Feb 18 06:54 PM
Brottem John L.	Officer	Feb 18 '25	Proposed Sale	0.90	6,145	5,530		Feb 18 06:52 PM
Ahmed Nabeel	Officer	Feb 18 '25	Proposed Sale	0.90	8,659	7,793		Feb 18 06:51 PM

LUNG

Pulmonx Corp

OM

Outset Medical Inc

Upgrade your FINVIZ experience